Searched for
ORAL CAPSULES
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...- Good news for diabetes & BP patients: Govt cuts prices of these 30 medicines, relief may reach pharmacies soonThe National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- HAB Pharma merges Signature Phytochemicals, eyes Rs3,000 crore revenue by 2030HAB Pharma and Signature Phytochemicals have merged, creating a consolidated entity with a turnover of Rs600 crore. This strategic move aim...
- War, oil price hikes, and risks: Time to still be contrarian? 5 small-caps from different sectors with upside potential of up to 25%Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Suven Pharma acquires Hyderabad-based formulation maker for Rs 155 croreSuven will purchase100% of share capital from CPPL existing investors. Suven didn't provide details like annual turnover of the acquired as...
- Hetero gets DCGI nod to manufacture, market Molnupiravir capsulesUnder the licensing deal, Hetero will be allowed to expand access of Molnupiravir in India and in other low-and middle-income countries, fo...
- Glenmark launches kidney cancer treatment drug in India priced 96% lower than innovator brandIn a regulatory filing, Glenmark Pharma said it launched "SUTIB, the generic version of Sunitinib oral capsules to treat kidney cancer in I...
- Scientists design new oral capsule that may end the era of painful insulin jabsMany drugs, especially those made of proteins, cannot be taken orally because they are broken down in the gastrointestinal tract before the...
- Lupin gets USFDA nod for antidepressant drugThe capsules are indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD), Lupin said.
- Natco Pharma launches Tamiflu generic capsules in USThe company's capsules are generic versions of Roche's Tamiflu drug
- Natco Pharma surges 7% on drug approvalThe stock rose 7.33 per cent to hit a high of Rs 650.90 on BSE. Volumes more than doubled on the counter to 98,000 shares, compared with a ...
- Natco Pharma gets ANDA nod for Tamiflu's generic versionTamiflu is used to treat the flu (influenza) in people 2 weeks of age and older who have had flu symptoms for no more than 2 days.
- Strides Shasun gets USFDA nod to market Dutasteride capsulesThe company has received approval from the US Food and Drug Administration (USFDA) to market Dutasteride capsules in the strength of 0.5 mg...
- Lupin gets USFDA nod to market generic version of CiproLupin said it has received US health regulator USFDA'S approval to market a generic version of Bayer's Cipro, used to treat infections, in ...
- Aurobindo Pharma gets USFDA nod for two drugsAurobindo Pharma today said it has received final approvals from US health regulator to sell generic versions of two separate drugs.
- Dr Reddy's launches Amoxicillin tablets, capsules in US marketDr Reddy's today announced the launch of antibiotic Amoxicillin tablets, capsules and oral suspension.
- Panacea's Baddi unit gets US FDA approvalDrug maker Panacea Biotec on Friday said its pharmaceutical facility at Baddi in Himachal Pradesh has received approval from US health regu...
Load More
